BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 37169934)

  • 1. Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy.
    Mukund A; Marri UK; Jindal A; Choudhury A; Patidar Y; Sarin SK
    Dig Dis Sci; 2023 Jul; 68(7):3174-3184. PubMed ID: 37169934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis.
    Wu W; Zhang H; Zeng Z; Wang X; Kong D
    Scand J Gastroenterol; 2022 Dec; 57(12):1494-1502. PubMed ID: 35802771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis.
    Qi X; Han G; He C; Yin Z; Zhang H; Wang J; Xia J; Cai H; Yang Z; Bai M; Wu K; Fan D
    Med Sci Monit; 2012 Aug; 18(8):HY37-41. PubMed ID: 22847208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.
    Rosenqvist K; Eriksson LG; Rorsman F; Sangfelt P; Nyman R
    Acta Radiol; 2016 May; 57(5):572-9. PubMed ID: 26253926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis.
    Klinger C; Riecken B; Schmidt A; De Gottardi A; Meier B; Bosch J; Caca K
    Z Gastroenterol; 2018 Mar; 56(3):221-237. PubMed ID: 29113006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
    Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
    Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
    Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
    Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access.
    Mansour N; Öcal O; Gerwing M; Köhler M; Deniz S; Heinzow H; Steib C; Angele MK; Seidensticker M; Ricke J; Wildgruber M
    Abdom Radiol (NY); 2022 Mar; 47(3):1177-1186. PubMed ID: 35020007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
    Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
    Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular Intrahepatic Portosystemic Shunt and Thrombectomy (TIPS-Thrombectomy) for Symptomatic Acute Noncirrhotic Portal Vein Thrombosis.
    Shalvoy MR; Ahmed M; Weinstein JL; Ramalingam V; Malik MS; Ali A; Shenoy-Bhangle AS; Curry MP; Sarwar A
    J Vasc Interv Radiol; 2023 Aug; 34(8):1373-1381.e3. PubMed ID: 37182668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort.
    Thornburg B; Desai K; Hickey R; Hohlastos E; Kulik L; Ganger D; Baker T; Abecassis M; Caicedo JC; Ladner D; Fryer J; Riaz A; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2017 Dec; 28(12):1714-1721.e2. PubMed ID: 29050854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis.
    Klinger C; Riecken B; Schmidt A; De Gottardi A; Meier B; Bosch J; Caca K
    Dig Liver Dis; 2017 Dec; 49(12):1345-1352. PubMed ID: 28733177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Lv Y; Bai W; Li K; Wang Z; Guo W; Luo B; Wang J; Wang Q; Wang E; Xia D; Li X; Yuan J; Han N; Niu J; Yin Z; Fan D; Han G
    Am J Gastroenterol; 2021 Jul; 116(7):1447-1464. PubMed ID: 33630766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy
    Jiang TT; Luo XP; Sun JM; Gao J
    World J Gastroenterol; 2017 Nov; 23(41):7470-7477. PubMed ID: 29151701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations.
    Thornburg B; Desai K; Hickey R; Kulik L; Ganger D; Baker T; Abecassis M; Lewandowski RJ; Salem R
    Tech Vasc Interv Radiol; 2016 Mar; 19(1):52-60. PubMed ID: 26997089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative portal vein recanalization-transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: Outcomes following liver transplantation.
    Talwar A; Varghese J; Knight GM; Katariya N; Caicedo JC; Dietch Z; Borja-Cacho D; Ladner D; Christopher D; Baker T; Abecassis M; Mouli S; Desai K; Riaz A; Thornburg B; Salem R
    Hepatol Commun; 2022 Jul; 6(7):1803-1812. PubMed ID: 35220693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic collateral-systemic shunt is effective for cavernous transformation of the portal vein with variceal bleeding.
    Tie J; Gou X; He C; Li K; Yuan X; Jia W; Niu J; Han N; Xu J; Zhu Y; Wang W
    Hepatol Int; 2023 Aug; 17(4):979-988. PubMed ID: 37097537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin prevented de novo portal vein thrombosis after transjugular intrahepatic portosystemic shunt: A retrospective study.
    Zhang L; Huan H; Tong H; Wei B; Wang Z; Liu C; Wu H
    Medicine (Baltimore); 2020 Jan; 99(2):e18737. PubMed ID: 31914090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.